AK 295
Modify Date: 2024-02-25 11:21:17
AK 295 structure
|
Common Name | AK 295 | ||
|---|---|---|---|---|
| CAS Number | 160399-35-9 | Molecular Weight | 504.62 | |
| Density | 1.145g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C26H40N4O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AK 295AK 295 (CX 295) is a calpain inhibitor that inhibits apoptosis through a calpain-dependent pathway. AK 295 improves neurological function in a rat model of spinal cord injury (SCI). AK 295 can be used in the study of neurodegenerative diseases, such as bulbar amyotrophy, stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis[1]. |
| Name | benzyl N-[(2S)-4-methyl-1-[[1-(3-morpholin-4-ylpropylamino)-1,2-dioxopentan-3-yl]amino]-1-oxopentan-2-yl]carbamate |
|---|---|
| Synonym | More Synonyms |
| Description | AK 295 (CX 295) is a calpain inhibitor that inhibits apoptosis through a calpain-dependent pathway. AK 295 improves neurological function in a rat model of spinal cord injury (SCI). AK 295 can be used in the study of neurodegenerative diseases, such as bulbar amyotrophy, stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis[1]. |
|---|---|
| Related Catalog | |
| Target |
Calpain[1]. |
| References |
| Density | 1.145g/cm3 |
|---|---|
| Molecular Formula | C26H40N4O6 |
| Molecular Weight | 504.62 |
| Exact Mass | 504.29500 |
| PSA | 133.05000 |
| LogP | 3.00340 |
| Index of Refraction | 1.524 |
| InChIKey | TZVQRMYLYQNBOA-KEKNWZKVSA-N |
| SMILES | CCC(NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1)C(=O)C(=O)NCCCN1CCOCC1 |
| AK 295 |
| Cbz-leu-abu-conh(CH2)3-mpl |
| CX 295 |
| Cbz-leu-aminobutyrate-conh(CH2)3-morpholine |